Evaluate’s Paul Verdin and Cem Baydar sat down with guest speaker Özgür Tuncer, Investment Partner at Ascension Life Fund, to address the key challenges facing biopharma investors. If you would like to revisit the data and review some of the key themes discussed, please download our webinar slides and on-demand video using the link below.
Discussion Topics:
- Where are the safe havens in uncertain times?
- Has the IPO window slammed shut?
- How much longer will venture funding remain the bright spot?
- How can the investment community effectively prioritise early stage investments?
